Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor
| Class:Id | LiteratureReference:444490 |
|---|---|
| _displayName | Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor |
| _timestamp | 2018-02-26 18:02:23 |
| author | [Person:444497] Perretti, M [Person:444540] Chiang, N [Person:140436] La, M [Person:444488] Fierro, IM [Person:390781] Marullo, S [Person:444486] Getting, SJ [Person:444482] Solito, E [Person:8862698] Serhan, Charles N |
| created | [InstanceEdit:444492] Jupe, S, 2009-10-23 |
| journal | Nat Med |
| modified | [InstanceEdit:9038365] D'Eustachio, Peter, 2018-02-26 |
| pages | 1296-302 |
| pubMedIdentifier | 12368905 |
| title | Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor |
| volume | 8 |
| year | 2002 |
| (literatureReference) | [Summation:416395] The N-formyl peptide receptor 2 (FPR2, LXA4 receptor, FPRL1)... [Summation:444542] FPRL2 is activated by the neuroprotective peptide humanin, a... |
| [Change default viewing format] | |
No pathways have been reviewed or authored by Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor (444490)
